| 注册
首页|期刊导航|陕西中医|扶正抗癌方联合化疗对晚期非小细胞肺癌患者血清肿瘤标志物的影响

扶正抗癌方联合化疗对晚期非小细胞肺癌患者血清肿瘤标志物的影响

张公正

陕西中医2017,Vol.38Issue(7):885-886,2.
陕西中医2017,Vol.38Issue(7):885-886,2.DOI:10.3969/j.issn.1000-7369.2017.07.036

扶正抗癌方联合化疗对晚期非小细胞肺癌患者血清肿瘤标志物的影响

Effects of Fuzheng Kang'ai prescription combined with chemotherapy on serum tumor markers in patients with advanced non small cell lung cancer

张公正1

作者信息

  • 1. 河南省平顶山市第二人民医院 平顶山467000
  • 折叠

摘要

Abstract

Objective:To explore the effect of integrated traditional Chinese and western medicine on serum tumor markers in patients with advanced non-small cell lung cancer.Methods:90 cases of non-small cell lung cancer patients were randomly divided into control group and observation group, 45 cases in each group, the control group were treated by chemotherapy treatment, observation group were treated with combined therapy of Fuzheng Kang''ai prescription, in the treatment of two groups of patients, after 2 months,4 months and 6 months were to detected statistical changes.Results:The curative effect evaluation showed that the total effective rate of observation group was 93.3%, significantly higher than 71.1% in the control group, the difference was statistically significant (P<0.05);two groups after the treatment, CA-125, CEA, NSE and CYFRA21-1 levels were significantly decreased, and the observation group was lower compared to the control group (P<0.05).Conclusion:The combined treatment of Fuzheng Kang''ai prescription for patients with advanced non-small cell lung cancer is worthy of recognition, can significantly reduce the level of serum tumor markers.

关键词

肺肿瘤/中西医结合疗法/化疗/@扶正抗癌方

Key words

Lung neoplasms/traditional and western medicine therapy/Chemotherapy/@Fuzheng Kang'ai prescription

分类

医药卫生

引用本文复制引用

张公正..扶正抗癌方联合化疗对晚期非小细胞肺癌患者血清肿瘤标志物的影响[J].陕西中医,2017,38(7):885-886,2.

陕西中医

1000-7369

访问量2
|
下载量0
段落导航相关论文